Literature DB >> 25287469

Cardiac autonomic dysregulation in acute schizophrenia.

Hsin-An Chang1, Chuan-Chia Chang1, Nian-Sheng Tzeng1, Terry B J Kuo2, Ru-Band Lu3, San-Yuan Huang1.   

Abstract

OBJECTIVE: Altered cardiac autonomic function has been proposed in schizophrenia, but the results are mixed. Therefore, analyses with larger sample sizes and better methodology are needed.
METHODS: To examine whether acute schizophrenia is associated with cardiac autonomic dysfunction, 314 unmedicated patients with acute schizophrenia and 409 healthy volunteers, aged 18-65 years, were recruited for a case-control analysis. The severity of schizophrenia symptoms was assessed with the Positive and Negative Syndrome Scale. Cardiac autonomic function was evaluated by measuring heart rate variability (HRV) parameters during the supine-standing-supine test. Frequency-domain indices of HRV were obtained.
RESULTS: Unmedicated patients with acute schizophrenia consistently exhibited reduced mean RR interval and HRV levels in a supine rest and standing position compared with healthy volunteers. The severity of psychopathology, in particular positive symptoms, was negatively correlated with cardiac vagal control.
CONCLUSION: These data suggest that acute schizophrenia is accompanied by cardiac autonomic dysregulation. In view of the higher risk for cardiac complications in these patients, one might also consider the antipsychotic treatment in favour of improving cardiac autonomic modulation. Further studies using larger patient groups and controlled therapeutics may better understand the influence of antipsychotic treatment on cardiac autonomic regulation in schizophrenia.

Entities:  

Year:  2013        PMID: 25287469     DOI: 10.1111/acn.12014

Source DB:  PubMed          Journal:  Acta Neuropsychiatr        ISSN: 0924-2708            Impact factor:   3.403


  8 in total

1.  Impact of sex and depressed mood on the central regulation of cardiac autonomic function.

Authors:  Ronald G Garcia; Klara Mareckova; Laura M Holsen; Justine E Cohen; Susan Whitfield-Gabrieli; Vitaly Napadow; Riccardo Barbieri; Jill M Goldstein
Journal:  Neuropsychopharmacology       Date:  2020-03-09       Impact factor: 7.853

Review 2.  Autonomic nervous system dysfunction in psychiatric disorders and the impact of psychotropic medications: a systematic review and meta-analysis.

Authors:  Gail A Alvares; Daniel S Quintana; Ian B Hickie; Adam J Guastella
Journal:  J Psychiatry Neurosci       Date:  2016-03       Impact factor: 6.186

Review 3.  Cardiac Autonomic Dysfunction in Patients with Schizophrenia and Their Healthy Relatives - A Small Review.

Authors:  Karl-Jürgen Bär
Journal:  Front Neurol       Date:  2015-06-24       Impact factor: 4.003

4.  Effects of long-acting injectable antipsychotics versus oral antipsychotics on autonomic nervous system activity in schizophrenic patients.

Authors:  Akira Suda; Saki Hattori; Ikuko Kishida; Masatoshi Miyauchi; Yohko Shiraishi; Mami Fujibayashi; Natsuki Tsujita; Chie Ishii; Norio Ishii; Toshio Moritani; Yoshio Hirayasu
Journal:  Neuropsychiatr Dis Treat       Date:  2018-09-17       Impact factor: 2.570

5.  The association of genetic polymorphisms in CYP1A2, UGT1A4, and ABCB1 with autonomic nervous system dysfunction in schizophrenia patients treated with olanzapine.

Authors:  Saki Hattori; Akira Suda; Masatoshi Miyauchi; Yohko Shiraishi; Takashi Saeki; Tadashi Fukushima; Mami Fujibayashi; Natsuki Tsujita; Chie Ishii; Norio Ishii; Tosiho Moritani; Yusuke Saigusa; Ikuko Kishida
Journal:  BMC Psychiatry       Date:  2020-02-18       Impact factor: 3.630

Review 6.  Autonomic nervous system dysfunction in schizophrenia: impact on cognitive and metabolic health.

Authors:  Margaret K Hahn; Sri Mahavir Agarwal; Nicolette Stogios; Alexander Gdanski; Philip Gerretsen; Araba F Chintoh; Ariel Graff-Guerrero; Tarek K Rajji; Gary Remington
Journal:  NPJ Schizophr       Date:  2021-04-26

7.  Capturing Rest-Activity Profiles in Schizophrenia Using Wearable and Mobile Technologies: Development, Implementation, Feasibility, and Acceptability of a Remote Monitoring Platform.

Authors:  Nicholas Meyer; Maximilian Kerz; Amos Folarin; Dan W Joyce; Richard Jackson; Chris Karr; Richard Dobson; James MacCabe
Journal:  JMIR Mhealth Uhealth       Date:  2018-10-30       Impact factor: 4.773

8.  Altered Autonomic Function in Individuals at Clinical High Risk for Psychosis.

Authors:  Anna Kocsis; Ruchika Gajwani; Joachim Gross; Andrew I Gumley; Stephen M Lawrie; Matthias Schwannauer; Frauke Schultze-Lutter; Tineke Grent-'t-Jong; Peter J Uhlhaas
Journal:  Front Psychiatry       Date:  2020-11-06       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.